Nigeria’s University of Benin unveils ‘cure’ for HIV/AIDS

A cure for Human Immunodeficiency Virus, HIV,
and Acquired Immunodeficiency Syndrome, AIDS,
has been discovered, a Professor at the University of
Benin said on Tuesday.
Isaiah Ibeh, the Dean of the School of Basic Medical
Science of the University, said in Benin that the
herbal drug has undergone "series of successful
tests".
"We are at the threshold of making history, in the
sense that we seem to have with us something that
will permanently take care of what over time seems
to have defied all solutions.
"We are talking about the latest discovery of an oral
drug made from plants extraction in Nigeria for the
possible cure of the pandemic, HIV and AIDS virus,"
he said.
Mr. Ibeh said research on the project started in 2010
and culminated in the development of "Deconcotion
X (DX)–Liquid or Bioclean 11 for the cure of HIV and
AIDS".
He said that while the existing retroviral drugs are
intervention drugs for the management of AIDS, the
new discovery is a possible cure.
"We have tried to look at the product first; its
toxicological analysis and discovered that it has a
large safety margin. This means that if animals or
human beings are exposed to it, they will not suffer
any serious harm at all from the exposure.
"It also helped us to know the quantity we can
conveniently give to animals and will feel secure that
nothing untoward will happen. We have also done
the bacteriological analysis on it, after which we
looked at its effect on the virus and the result was
quite revealing and refreshing."
Mr. Ibeh also said that the drug had been exposed to
series of medical examination both in Nigeria and in
the USA.
He added that the drug had performed well on
patients with the HIV virus and had shown evidence
of total restoration of damaged tissues.
"The result showed an increase in the body weight of
the individual administered with DX," he said. "The
body weight was statistically significant when
compared with the control group."
He said that further tests were being conducted to
determine the point at which "a patient becomes
negative after being administered the drug?"
"This verification is necessary because it is what is
used to measure whether infection is still there or
not. So we need to know the siro-convention time.
"But preliminary results showed that of the five
latest patients orally administered with the drugs,
our findings is that up to seven months , three of
them were siro negative while two were sill faintly
positive," he said.
Mr. Ibeh appealed for support from the Federal
Government and relevant bodies to assist the
university with relevant equipment to sustain the
research.
NAN
Sent from my BlackBerry wireless device from MTN